Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
HitIQ Limited ( (AU:HIQ) ) has provided an announcement.
HITIQ Limited has announced the first deployment of its PROTEQT™ instrumented mouthguards in the United States, marking a significant expansion into the American collegiate sports research market. This strategic move involves a partnership with Smith College’s Motor Neuroscience and Neuroimaging Laboratory to study concussion risks in women’s rugby, an area with growing participation and institutional support. The collaboration positions PROTEQT™ as a key technology in concussion research, potentially influencing broader adoption across the US collegiate athletics market, which includes over 500,000 NCAA student-athletes.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
More about HitIQ Limited
HITIQ Limited operates in the sports technology industry, specializing in instrumented mouthguards designed to monitor and analyze head impacts in sports. The company focuses on enhancing athlete safety and concussion management, with a particular emphasis on the collegiate sports market.
Average Trading Volume: 655,739
Technical Sentiment Signal: Buy
Current Market Cap: A$12.67M
For an in-depth examination of HIQ stock, go to TipRanks’ Overview page.